Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

What action is FDA considering to address concerns related to these medication errors?

April 26, 2017Action address concerns considering errors fda medication

0

Posted

What action is FDA considering to address concerns related to these medication errors?

1 Answer

0

Posted

Since the time of FDA approval of edetate disodium for use in the treatment of hypercalcemia or digitalis toxicity, multiple new drugs have been developed and marketed for treatment of these same conditions. Based on the availability of other drugs that can be used for the indications for which edetate disodium was approved, and the safety issues related to edetate disodium, FDA is reconsidering the overall risks and benefits of edetate disodium to determine the most appropriate action. FDA is also issuing a Public Health Advisory regarding edetate disodium. 7. What action is FDA considering regarding edetate calcium disodium? FDA is issuing a Public Health Advisory regarding the medication errors involving edetate disodium and edetate calcium disodium. FDA is not considering additional action regarding edetate calcium disodium at this time. Edetate calcium disodium is approved for use in the treatment of lead poisoning. Few drugs are available for treatment of this serious condition.